staphylococcus toxoid
Vaccinemarketed
Approved
Jul 1, 1933
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jun 20, 2025 (NCT06895460)
Timeline
1930s
- Jul 1, 1933
Evidence of US Marketing
2020s
- Jan 1, 2025
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Studied for
Mechanism of action
- Staphylococcus sp.Immunity, active
Staphylococcus sp. immunity, active
Approval history
- approvedJul 1, 1933
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- staphylococcus toxoid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06895460 | Phase 3 | Jun 20, 2025 | Nanjing Medical University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Nanjing Medical University | Academic/Hospital | 1 | 1 | 1 | 2025 |
1 organizations
Page 1 / 1